tradingkey.logo

Harvard Bioscience Inc

HBIO
View Detailed Chart

0.467USD

-0.203-30.32%
Close 05/30, 16:00ETQuotes delayed by 15 min
20.65MMarket Cap
LossP/E TTM

Harvard Bioscience Inc

0.467

-0.203-30.32%
Intraday
1m
30m
1h
D
W
M
D

Today

-30.32%

5 Days

+38.91%

1 Month

+31.07%

6 Months

-78.77%

Year to Date

-77.87%

1 Year

-85.27%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
3.000
Target Price
542.40%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Harvard Bioscience Inc
HBIO
2
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Intuitive Surgical Inc
ISRG
33
Thermo Fisher Scientific Inc
TMO
33
Veeva Systems Inc
VEEV
32
1
2
3
...
18

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(4)
Neutral(4)
Buy(5)
Indicators
Sell(2)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.058
Neutral
RSI(14)
54.632
Neutral
STOCH(KDJ)(9,3,3)
35.012
Neutral
ATR(14)
0.121
Low Volatility
CCI(14)
119.259
Buy
Williams %R
72.054
Sell
TRIX(12,20)
-0.086
Sell
StochRSI(14)
52.561
Neutral
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
0.426
Buy
MA10
0.380
Buy
MA20
0.356
Buy
MA50
0.420
Buy
MA100
0.888
Sell
MA200
1.681
Sell

News

More news coming soon, stay tuned...

Company

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
Company codeHBIO
CompanyHarvard Bioscience Inc
CEOMr. James W. (Jim) Green
Websitehttps://www.harvardbioscience.com/
KeyAI